{"downloaded": true, "htmlmade": false, "full": {"id": "33104043", "source": "MED", "pmid": "33104043", "pmcid": "PMC7990399", "fullTextIdList": {"fullTextId": "PMC7990399"}, "doi": "10.3233/jpd-202302", "title": "Genetics of Progressive Supranuclear Palsy: A Review.", "authorString": "Wen Y, Zhou Y, Jiao B, Shen L.", "authorList": {"author": [{"fullName": "Wen Y", "firstName": "Yafei", "lastName": "Wen", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China."}}}, {"fullName": "Zhou Y", "firstName": "Yafang", "lastName": "Zhou", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Geriatrics Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China."}}}, {"fullName": "Jiao B", "firstName": "Bin", "lastName": "Jiao", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China."}, {"affiliation": "National Clinical Research Center for Geriatric Disorders, Central South University, Changsha, Hunan, PR China."}, {"affiliation": "Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, PR China."}]}}, {"fullName": "Shen L", "firstName": "Lu", "lastName": "Shen", "initials": "L", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China."}, {"affiliation": "National Clinical Research Center for Geriatric Disorders, Central South University, Changsha, Hunan, PR China."}, {"affiliation": "Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, PR China."}, {"affiliation": "Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, Changsha, Hunan, PR China."}]}}]}, "dataLinksTagsList": {"dataLinkstag": ["altmetrics", "supporting_data"]}, "journalInfo": {"issue": "1", "volume": "11", "journalIssueId": "3108870", "dateOfPublication": "2021", "monthOfPublication": "0", "yearOfPublication": "2021", "printPublicationDate": "2021-01-01", "journal": {"title": "Journal of Parkinson's disease", "ISOAbbreviation": "J Parkinsons Dis", "medlineAbbreviation": "J Parkinsons Dis", "NLMid": "101567362", "ISSN": "1877-7171", "ESSN": "1877-718X"}}, "pubYear": "2021", "pageInfo": "93-105", "abstractText": "Progressive supranuclear palsy (PSP) is an atypical parkinsonism with prominent 4R-tau neuropathology, and the classical clinical phenotype is characterized by vertical supranuclear gaze palsy, unprovoked falls, akinetic-rigid syndrome and cognitive decline. Though PSP is generally regarded as sporadic, there is increasing evidence suggesting that a series of common and rare genetic variants impact on sporadic and familial forms of PSP. To date, more than 10 genes have been reported to show a potential association with PSP. Among these genes, the microtubule-associated protein tau (MAPT) is the risk locus with the strongest effect size on sporadic PSP in the case-control genome-wide association studies (GWAS). Additionally, MAPT mutations are the most common cause of familial PSP while the leucine-rich repeat kinase 2 (LRRK2) is a rare monogenic cause of PSP, and several other gene mutations may mimic the PSP phenotype, like the dynactin subunit 1 (DCTN1). In total, 15 MAPT mutations have been identified in cases with PSP, and the mean age at onset is much earlier than in cases carrying LRRK2 or DCTN1 mutations. GWAS have further identified several risk loci of PSP, proposing molecular pathways related to PSP. The present review focused on genetic studies on PSP and summarized genetic factors of PSP, which may help to elucidate the underlying pathogenesis and provide new perspectives for therapeutic strategies.", "affiliation": "Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "review-article", "Review", "Journal Article"]}, "keywordList": {"keyword": ["Genetics", "Variants", "Mutations", "haplotype", "microtubule-associated protein tau", "Genome-wide Association Study", "Progressive Supranuclear Palsy"]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/JPD-202302"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7990399"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7990399?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "1", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "refsnp"}, "dateOfCreation": "2020-10-26", "firstIndexDate": "2020-10-26", "fullTextReceivedDate": "2021-04-22", "dateOfRevision": "2021-04-15", "firstPublicationDate": "2021-01-01"}, "htmllinks": "https://europepmc.org/articles/PMC7990399", "abstract": "Progressive supranuclear palsy (PSP) is an atypical parkinsonism with prominent 4R-tau neuropathology, and the classical clinical phenotype is characterized by vertical supranuclear gaze palsy, unprovoked falls, akinetic-rigid syndrome and cognitive decline. Though PSP is generally regarded as sporadic, there is increasing evidence suggesting that a series of common and rare genetic variants impact on sporadic and familial forms of PSP. To date, more than 10 genes have been reported to show a potential association with PSP. Among these genes, the microtubule-associated protein tau (MAPT) is the risk locus with the strongest effect size on sporadic PSP in the case-control genome-wide association studies (GWAS). Additionally, MAPT mutations are the most common cause of familial PSP while the leucine-rich repeat kinase 2 (LRRK2) is a rare monogenic cause of PSP, and several other gene mutations may mimic the PSP phenotype, like the dynactin subunit 1 (DCTN1). In total, 15 MAPT mutations have been identified in cases with PSP, and the mean age at onset is much earlier than in cases carrying LRRK2 or DCTN1 mutations. GWAS have further identified several risk loci of PSP, proposing molecular pathways related to PSP. The present review focused on genetic studies on PSP and summarized genetic factors of PSP, which may help to elucidate the underlying pathogenesis and provide new perspectives for therapeutic strategies.", "Keywords": ["Genetics", "Variants", "Mutations", "haplotype", "microtubule-associated protein tau", "Genome-wide Association Study", "Progressive Supranuclear Palsy"], "pdflinks": "https://europepmc.org/articles/PMC7990399?pdf=render", "journaltitle": "Journal of Parkinson's disease", "authorinfo": ["Wen Y", "Zhou Y", "Jiao B", "Shen L"], "title": "Genetics of Progressive Supranuclear Palsy: A Review."}